Patients' perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial

Heart
Anne GammelgaardDANAMI-2 Investigators

Abstract

To analyse how patients in the acute phase of a myocardial infarct experience the informed consent procedure of a clinical trial. A questionnaire based follow up survey including patients who gave informed consent as well as patients who did not consent to the trial. 103 patients who gave informed consent and 78 who did not consent to the second Danish acute myocardial infarction trial (DANAMI-2). 76% of the trial participants and 63% of the non-participants agreed or mostly agreed that they felt able to make a decision about whether or not to participate in the trial; 50% of the trial participants and 34% of the non-participants found it acceptable that patients in their situation have to make such a decision. Only 28% of the trial participants and 7% of the non-participants read the information sheet before they made the decision. Informed consent should be sought in acute myocardial infarction trials despite the emergency situation and the medical condition of the patients. Patients' self assessed ability to make a decision should be explicitly addressed during the informed consent process and patients should not be pressurised into decision making. Physicians and research ethics committees should focus specifically on impro...Continue Reading

References

Mar 11, 1999·The New England Journal of Medicine·R D TruogA Morris
Aug 27, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·H A SmithlineB J Crenshaw
Aug 22, 2003·The New England Journal of Medicine·Henning R AndersenUNKNOWN DANAMI-2 Investigators
Mar 30, 2004·Social Science & Medicine·Anne GammelgaardUNKNOWN DANAMI-2 Investigators
Sep 17, 2004·The Journal of Medicine and Philosophy·Anne Gammelgaard

❮ Previous
Next ❯

Citations

Feb 16, 2006·Intensive Care Medicine·Catherine ChenaudBara Ricou
Jan 23, 2008·Science and Engineering Ethics·Piotr S Iwanowski
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Anders Agård
Apr 21, 2007·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Denise KendrickUNKNOWN UK Burden of Injury Study Group
Dec 13, 2006·Critical Care : the Official Journal of the Critical Care Forum·Catherine ChenaudBara Ricou
Feb 24, 2007·Critical Care : the Official Journal of the Critical Care Forum·Robert D Truog
May 15, 2013·Journal of Medical Ethics·Alexander T LimkakengRicardo Pietrobon
Sep 24, 2010·QJM : Monthly Journal of the Association of Physicians·T Agoritsas, T V Perneger
Jan 3, 2015·Acute Cardiac Care·Neal W DickertHabib Samady
Dec 12, 2012·Progress in Cardiovascular Diseases·Neal W DickertHabib Samady
Mar 5, 2016·Social Work in Health Care·Michael C SouleJeff C Huffman
Dec 29, 2015·Annals of Emergency Medicine·Neal W DickertRobert Silbergleit
Oct 27, 2005·Internal Medicine Journal·D Henderson
Jun 29, 2010·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Judith E ArnetzBengt B Arnetz
Apr 18, 2015·Bulletin of the World Health Organization·Nguyen Thanh TamJuntra Karbwang
Aug 12, 2016·Critical Care Medicine·David WendlerJeremy Brown
Jan 1, 2017·Journal of Medical Ethics·Neal W DickertAlexandra E Fehr
Oct 4, 2018·Clinical Trials : Journal of the Society for Clinical Trials·Neal W DickertScott Yh Kim
May 5, 2020·The American Journal of Bioethics : AJOB·Neal W DickertRebecca D Pentz
Nov 9, 2019·Journal of the American Heart Association·Victoria M SciclunaNeal W Dickert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.